| |
|
Form Serial Number: |
CS20180108E00347 |
| 1.
Date of relevant event: |
13/10/2017
(dd/mm/yyyy)
|
| 2.
Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later): |
08/01/2018
(dd/mm/yyyy)
|
| 3.
Stock code: |
01143 |
| 4.
Name of listed corporation: |
China Healthcare Enterprise Group Limited |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
4,955,311,400 |
| 7.
Name of substantial shareholder: |
CHINA HUARONG INTERNATIONAL HOLDINGS LTD |
| 8.
Registered office: |
China Huarong Tower, No. 60 Gloucester Road, Wan Chai, Hong Kong |
| 9.
Principal place of business in Hong Kong: |
China Huarong Tower, No. 60 Gloucester Road, Wan Chai, Hong Kong |
| 15.
Exchange on which listed: |
N/A |
| 16.
Name of listed parent and exchange on which parent is listed: |
N/A |
|
| 17.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved |
Currency of transaction |
On Exchange
|
Off Exchange
|
| Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Nature of consideration
|
|
Long position |
| 1201 | The percentage level of your interest in the shares has reduced because:
you completed a sale of the shares |
|
| 2201 | Interest of corporation controlled by you |
|
|
718,600,000 |
HKD |
|
|
0.1980 |
| 3102 | Assets other than cash |
|
| Short position |
|
|
|
|
|
|
|
|
|
|
|
| 18.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 718,600,000 | 14.50 |
|
|
| 19.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 0 | 0.00 |
|
|
| 20.
Capacity in which interests disclosed in Box 19 are held: |
| Capacity code | Number of shares |
| | |
|
|
|
|
| 21.
Further information in respect of derivative interests: |
| Derivatives code | Number of shares |
| | |
|
|
| 22.
Further information in relation to interests of corporations controlled by substantial shareholder: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| | | | | |
|
|
|
| 23.
Further information in relation to interests held by substantial shareholder jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
|
| 24.
Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust: |
| Names of trust | Address | Status code | Number of shares |
| | | |
|
|
| 25.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a substantial shareholder is interested under sections 317 and 318 | |
|
|
| 26.
Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act: |
| Names | Address | Relationship Code | Percentage (%) |
| | | |
|
| |
| 27.
Supplementary information: |
A disposal of the entire interest in Partners Special Investment Fund SP2 from Azaleas Investment Holding Limited, a direct wholly-owned subsidiary of China Huarong International Holdings Limited, to a third party (Peak Achiever Limited) took place on 11 October 2017 (the "SP2 Disposal"). SP2 held 738,400,000 ordinary shares of China Healthcare Enterprise Group Limited. The transfer of 718,600,000 ordinary shares of China Healthcare Enterprise Group Limited took place on 13 October 2017.
|
| 28.
Log/Serial Number of the previous form: |
|
| 29.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 2: |
08/01/2018
(dd/mm/yyyy)
|
|
|
|
|